central nervous system vasculitis
Recently Published Documents


TOTAL DOCUMENTS

285
(FIVE YEARS 71)

H-INDEX

33
(FIVE YEARS 4)

Author(s):  
Verónica Cabreira ◽  
Leonor Dias ◽  
Bruno Fernandes ◽  
Ana Aires ◽  
Joana Guimarães ◽  
...  

2021 ◽  
pp. 75-78
Author(s):  
Francisco Javier Rivas Ruvalcaba ◽  
Melissa Hernández-Vega ◽  
Arturo González-Lara ◽  
Ildefonso Rodríguez-Leyva

2021 ◽  
Vol 429 ◽  
pp. 118840
Author(s):  
Silvio Piffer ◽  
Raffaella Tanel ◽  
Roberto Bortolotti ◽  
Umberto Rozzanigo ◽  
Bruno Giometto ◽  
...  

2021 ◽  
Vol 5 (8) ◽  
Author(s):  
Luís Beck-da-Silva ◽  
Alexandre Maulaz ◽  
Paulo Schvartzman ◽  
Francine Hehn Oliveira ◽  
Jonathas Stifft ◽  
...  

Abstract Background Epigastric or chest pain with an abnormal electrocardiogram (ECG) in a young, otherwise healthy patient should trigger an investigation to rule out myocarditis. The myocarditis covers a wide spectrum of severity. The search for the aetiologic factor could be definitive for the success of therapy. Case summary A previously healthy 29-year-old woman presented to the Emergency Room with epigastric pain, eosinophilia, and an abnormal ECG. A thorough evaluation including cardiac magnetic resonance and endomyocardial biopsy was undertaken. A diagnosis of acute necrotizing eosinophilic myocarditis was made. Discussion The case is particularly unique for its suspected predisposing trigger: an antimigraine drug. A possible systemic hypersensitivity reaction, reflected by the occurrence of concomitant severe serum eosinophilia, acute myocarditis, and central nervous system vasculitis, was successfully treated with steroids, further supporting the diagnosis.


Author(s):  
Maximilian Patzig ◽  
Robert Forbrig ◽  
Clemens Küpper ◽  
Ozan Eren ◽  
Tobias Saam ◽  
...  

Abstract Objective To approach the clinical value of MRI with vessel wall imaging (VWI) in patients with central nervous system vasculitis (CNSV), we analyzed patterns of VWI findings both at the time of initial presentation and during follow-up. Methods Stenoocclusive lesions, vessel-wall contrast enhancement (VW-CE) and diffusion-restricted lesions were analyzed in patients with a diagnosis of CNSV. On available VWI follow-up, progression, regression or stability of VW-CE were evaluated and correlated with the clinical status. Results Of the 45 patients included, 28 exhibited stenoses visible on MR angiography (MRA-positive) while 17 had no stenosis (MRA-negative). VW-CE was found in 2/17 MRA-negative and all MRA-positive patients (p < 0.05). 79.1% (53/67) of stenoses showed VW-CE. VW-CE was concentric in 88.3% and eccentric in 11.7% of cases. Diffusion-restricted lesions were found more frequently in relation to stenoses with VW-CE than without VW-CE (p < 0.05). 48 VW-CE lesions in 23 patients were followed over a median time of 239.5 days. 13 VW-CE lesions (27.1%) resolved completely, 14 (29.2%) showed partial regression, 17 (35.4%) remained stable and 4 (8.3%) progressed. 22/23 patients received immunosuppressive therapy for the duration of follow-up. Patients with stable or progressive VW-CE were more likely (p < 0.05) to have a relapse (14/30 cases) than patients with partial or complete regression of VW-CE (5/25 cases). Conclusion Concentric VW-CE is a common finding in medium/large-sized vessel CNSV. VW-CE might represent active inflammation in certain situations. However, follow-up VWI findings proved ambiguous as persisting VW-CE despite immunosuppressive therapy and clinical remission was a frequent finding.


2021 ◽  
Author(s):  
Nathan Arnett ◽  
Athanasios Pavlou ◽  
Morgan P. Burke ◽  
Brett L. Cucchiara ◽  
Rennie L. Rhee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document